Danaher (DHR) Tops Q3 EPS by 17c
Tweet
Share
E-mail
Get Alerts DHR Hot Sheet
Price: $207.66 -1.6%
EPS Growth %: +1.6%
Financial Fact:
Selling, general and administrative expenses: -1.35B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +1.6%
Financial Fact:
Selling, general and administrative expenses: -1.35B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
(Updated - October 21, 2025 6:09 AM EDT)
Danaher (NYSE: DHR) reported Q3 EPS of $1.89, $0.17 better than the analyst estimate of $1.72. Revenue for the quarter came in at $6.05 billion versus the consensus estimate of $6 billion.
GUIDANCE:
Danaher sees FY2025 EPS of $7.70-$7.80, versus the consensus of $7.78.
For earnings history and earnings-related data on Danaher (DHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
